|
Published by: Kalorama Information
Published: Sep. 1, 2009 - 110 Pages
Table of Contents
TABLE OF CONTENTS
CHAPTER ONE: EXECUTIVE SUMMARY
- Market Drivers
- Market Size and Growth
- Total Implantable/Injectable Drug Delivery Marke
- The Implantable/Injectable Drug Delivery Only Market
- Competitor and Market Analysis
CHAPTER TWO: INTRODUCTION
- Scope and Methodology
- Reasons for Injectable/Implantable Drug Delivery Systems
- History of Injectable/Implantable Drug Delivery
- Phases of Drug Action
- Needle-Free Drug Delivery
- Auto-injectors
- Pen Injectors
- Major Applications
- Safety Concerns
- Products
- Implantable Drug Delivery
- Mechanisms
- Applications
- Products
- Sustained-Release Drug Delivery
- Products
- Targeted Injection Drug Delivery
- Products
- Lipsome
- Niosome
- Microspheres and Nanoparticles
- Cyclodetrins
- Prodrug
- Polymeric Micelles
PEGylation
CHAPTER THREE: TRENDS AND DEVELOPMENTS
- Drivers of the Implantable/Injectable Drug Delivery Market
- Pen Injectors
- Proprietary Product Development
- Delivery Systems Placement Trends
- Therapeutic Trends
- Incorporation of Technology
- Nanotechnology
- Drug Delivery Development
- Microsphere Technology
- Targeted Technology
- MicroChip Technology
- Protein-Coated Microcrystal Technology
- Needle-Free Delivery Development
- Selected Products in Development
CHAPTER FOUR: MARKET SIZE AND GROWTH
- The Total Implantable/Injectable Drug Delivery Market
- Injectable/Implantable Delivery Technology Only Market
CHAPTER FIVE: COMPETITIVE AND MARKET ANALYSIS
- Competitive Landscape
- Market Analysis
CHAPTER SIX: COMPANY PROFILES
- Alkermes, Inc.
- ALZA Corp.
- Antares Pharma, Inc.
- Bioject Medical Technologies, Inc.
- CyDex, Inc.
- MGI Pharma, Inc
- Nektar Therapeutics
- Pacira Pharmaceuticals, Inc.
- pSivida
- SurModics, Inc
- Zogenix Corporation
COMPANIES IN BRIEF
- AP Pharma
- Baxter BioPharma Solutions
QLT USA, Inc
- Ypsomed Holding AG
APPENDIX: COMPANY DIRECTORY
TABLE OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
- Figure 1-1
The Worldwide Market for Implantable/Injectable Drug Delivery Technology and Pharmaceuticals 2003-201
CHAPTER TWO: INTRODUCTION
- Table 2-1
Sequence of Drug Action
- Table 2-2
Marketed Products Using Liposomal Drug Delivery
- Table 2-3
Marketed Products Using Nanoparticle Drug Delivery
CHAPTER THREE: TRENDS AND DEVELOPMENTS
- Table 3-1
Select Products in Development by Drug Delivery Companies
CHAPTER FOUR: MARKET SIZE AND GROWTH
- Table 4-1
The Worldwide Market for Implantable/Injectable Drug Delivery Technology and Pharmaceuticals 2003-2013
- Figure 4-1
The Worldwide Market for Implantable/Injectable Drug Delivery Technology and Pharmaceuticals 2003-2013
- Table 4-2
The Worldwide Market for Pharmaceuticals Utilizing Injectable/Implantable Drug Delivery by Type 2003-2013
- Figure 4-2
The Worldwide Market for Pharmaceuticals Utilizing Injectable/Implantable Drug Delivery by Type 2003-2013
- Table 4-3
The Worldwide Market for Pharmaceuticals Utilizing Injectable/Implantable Drug Delivery Market Share by Type 2003-2013
- Figure 4-3
The Worldwide Market for Pharmaceuticals Utilizing Injectable/Implantable Drug Delivery Market Share by Type 2008
- Figure 4-4
The Worldwide Market for Pharmaceuticals Utilizing Injectable/Implantable Drug Delivery Market Share by Type 2013
- Table 4-4
The Worldwide Market for Injectable/Implantable Drug Delivery Systems by Pharmaceutical and Drug Delivery Component 2003-2013
- Table 4-5
The Worldwide Market for Injectable/Implantable Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2003-2013
- Figure 4-5
The Worldwide Market for Injectable/Implantable Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2008
- Figure 4-6
The Worldwide Market for Injectable/Implantable Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2013
CHAPTER FIVE: COMPETITIVE AND MARKET ANALYSIS
- Table 5-1
Leading Suppliers of Implantable/Injectable Drug Delivery Technology
- Figure 5-1
Cost per Million Injections by Injector Type
AbstractWith pharmaceutical companies increasingly looking for ways to extend the revenue-earning lifetime of their biggest products, drug delivery has become an important focus of the industry. Kalorama’s Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems provides detail for business planners on the market for implantable / injectable delivery system markets.
Biopharmaceutical products are driving growth of needle-free systems; there will likely be significant increases in revenues in the vaccine arena. This report looks at that trend and reports current and forecasted revenues for the implantable/injectable drug delivery market, segmented into two main categories:
- Needle-free drug delivery
- Other Injectable/Implantable
Kalorama's unique analysis offers segmentation of this market for:
- Drug Delivery Technology Revenues
- Pharmaceuticals Sold via Delivery Technology
This breakout makes the report relevant to business plans of either device technology companies or pharmaceutical concerns. (This market analysis does not include drug-eluding stents or prefilled or regular syringes. Kalorama considers these separate markets)
The report covers both pharmaceuticals sold through implantable/injectable delivery systems and the technologies themselves including:
- Detailed Profiles of Key Companies in Implantable/Injectable Delivery
- Brief Round-Up of Smaller Players
- Current Market Size and Forecasts to 2013
- Needle-Free Cost Savings, Protein-Coated Microcrystal Technology, Nanotechnology, and Other Trends and Developments
- Revenue Forecasts
- New Products in Development
Kalorama’s trusted information-gathering process provides most accurate study of the implantable/injectable delivery drug market available today. Information and analysis presented in this report is based on extensive interviews with senior management of top companies in the industry. While major research literature and government information is culled, information is corroborated and key market insights originate from interviews with industry leaders.
Companies Profiled in the report include:
- Alkermes, Inc.
- ALZA Corp.
- Antares Pharma, Inc.
- Bioject Medical Technologies, Inc.
- CyDex, Inc.
- MGI Pharma, Inc
- Nektar Therapeutics
- Pacira Pharmaceuticals, Inc.
- pSivida
- SurModics, Inc
- Zogenix Corporation
- AP Pharma
- Baxter BioPharma Solutions
- QLT USA, Inc
- Ypsomed Holding AG
Kalorama has also published Drug Delivery Markets: Oral Delivery, which details markets for oral technology enhancements which have increased drug product sales and extended patent life.
Get Full Details About This Report >>
|
